Aprocitentan
-
Idorsia Therapeutics Poised to Cut Hundreds of Jobs in Restructuring
Idorsia Therapeutics is negotiating to sell global rights to its high blood pressure drug amid a restructuring that could eliminate up to 270 positions, writes…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
